In the world of healthcare data, there has always been an uneasy balance between privacy and innovation.
The healthcare industry has historically operated under a culture of caution, often withholding data out of fear of HIPAA violations or penalties, which has fostered a “when in doubt, don’t share” mentality.
Now, however, the pendulum may be swinging in the direction of innovation.
An information-blocking “crackdown” by the U.S. Department of Health and Human Services (HHS) is intended to penalize companies or other entities that restrict patients’ access to their own electronic health information.
HHS has devoted additional resources towards enforcement of the information blocking rule and has vowed to take action to hold violators accountable, reducing the likelihood of future information blocking.
The new rule helps bring into focus some of the significant ethical implications of patient data use in healthcare, such as user consent and control, opt-in bias, and monetization.
Reframing the conversation around innovation and privacy
The enforcement of information blocking regulations marks a turning point in how healthcare organizations think about data. No longer is it enough to default to silence out of fear of noncompliance. Now, the onus is on organizations to justify why they aren’t sharing data, not why they are.
This change challenges the industry to shift from a defensive posture to one that recognizes responsible data sharing as a moral and operational imperative. It opens the door to a more balanced model that protects patient privacy while enabling legitimate data use that advances research, care coordination, and health equity.
At the heart of this cultural evolution is a mindset change from “no, because” to “yes, if.” This means building systems and policies that make sharing the default when key conditions are met, such as robust privacy safeguards, transparent consent processes, and accountability mechanisms. When organizations embrace this balance, they foster a climate of innovation built on trust rather than fear.
A critical next step involves modernizing consent frameworks. Current systems often force patients into all-or-nothing choices, limiting both their autonomy and the utility of their data. Patients gain agency from more nuanced consent models where individuals can specify who accesses their data, for what purpose, and for how long. This granular approach encourages participation and fuels progress, while still ensuring that ethical boundaries remain intact. Ultimately, the conversation isn’t about diminishing privacy; it’s about redefining it as an enabler of innovation rather than its obstacle.
A new approach to data democratization
Outside of healthcare, data sharing is already deeply woven into everyday life. Every day on Instagram, LinkedIn, and Google, for example, individuals willingly trade personal information for convenience, personalization, or social connection.
Healthcare, however, presents unique risks: Misuse of sensitive data could affect insurance coverage, employment, or even public perception. The core challenge is not the data itself but the lack of true user control. If individuals could dictate exactly how, when, and by whom their health data is used, and revoke that permission at any time, many would choose to share it. Transparent consent and fair compensation could transform data sharing into a system that benefits both patients and innovation alike.
Imagine a model where individuals can license their de-identified health data for research, clinical trials, or public health initiatives while earning compensation for their contributions. Such a framework could create a more equitable data economy while unlocking significant value for the broader healthcare system.
However, it must be designed carefully to avoid bias. Over-reliance on financial incentives, for instance, could lead to overrepresentation of certain groups. Balancing motivations through community-based benefits, charitable options, and inclusive outreach will be critical to ensuring equity and diversity in participation.
Synthetic data offers a temporary workaround for privacy constraints, but it remains an imperfect substitute for real-world insights. While AI-generated datasets can simulate patient populations, true progress depends on responsibly governed access to authentic, consented data. When individuals are empowered to share data under clear terms, the need for synthetic alternatives diminishes.
Meanwhile, AI and machine learning are reshaping how healthcare professionals interact with data. These tools can synthesize vast amounts of information, summarizing records, surfacing relevant insights, and contextualizing patient histories, to help clinicians make faster, more informed decisions. By amplifying human expertise rather than replacing it, AI helps close knowledge gaps and extend high-quality care to underserved populations. In this way, democratized data and AI together hold the potential to make healthcare more efficient, more equitable, and more human-centered.
Conclusion
The path forward for healthcare data lies not in choosing between privacy and innovation, but in harmonizing the two. Strong consent frameworks, transparent governance, and a shift toward patient empowerment can transform data from a source of fear into a force for progress. By embracing thoughtful risk, enabling ethical sharing, and leveraging technology responsibly, the industry can rebalance the scales between privacy and progress.
About Patrick Lane
Patrick J. Lane is President and Chief Operating Officer of Health Gorilla, where he leads enterprise operations and strategy for one of the nation’s designated QHINs. With more than 25 years of experience, he has built and scaled technology businesses across healthcare and other regulated industries, driving disciplined growth, operational transformation, and long-term value creation.
